HomeCompareAZRX vs PEP

AZRX vs PEP: Dividend Comparison 2026

AZRX yields 57.97% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AZRX wins by $447.6K in total portfolio value
10 years
AZRX
AZRX
● Live price
57.97%
Share price
$3.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$589.5K
Annual income
$134,189.34
Full AZRX calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — AZRX vs PEP

📍 AZRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAZRXPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AZRX + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AZRX pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AZRX
Annual income on $10K today (after 15% tax)
$4,927.54/yr
After 10yr DRIP, annual income (after tax)
$114,060.94/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, AZRX beats the other by $61,466.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AZRX + PEP for your $10,000?

AZRX: 50%PEP: 50%
100% PEP50/50100% AZRX
Portfolio after 10yr
$365.7K
Annual income
$98,032.51/yr
Blended yield
26.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

AZRX
Analyst Ratings
4
Buy
Consensus: Buy
Altman Z
-1.8
Piotroski
6/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AZRX buys
0
PEP buys
0
No recent congressional trades found for AZRX or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAZRXPEP
Forward yield57.97%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$589.5K$141.9K
Annual income after 10y$134,189.34$61,875.67
Total dividends collected$485.6K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: AZRX vs PEP ($10,000, DRIP)

YearAZRX PortfolioAZRX Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$16,497$5,797.10$10,849$509.42+$5.6KAZRX
2$26,590$8,937.89$11,969$750.47+$14.6KAZRX
3$41,915$13,463.51$13,500$1,124.14+$28.4KAZRX
4$64,683$19,834.65$15,680$1,721.66+$49.0KAZRX
5$97,818$28,606.69$18,929$2,715.34+$78.9KAZRX
6$145,096$40,430.56$24,023$4,450.80+$121.1KAZRX
7$211,301$56,048.29$32,510$7,669.92+$178.8KAZRX
8$302,374$76,282.53$47,709$14,093.60+$254.7KAZRX
9$425,560$102,019.99$77,415$28,083.48+$348.1KAZRX
10$589,539$134,189.34$141,922$61,875.67+$447.6KAZRX

AZRX vs PEP: Complete Analysis 2026

AZRXStock

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine pancreatic insufficiency (EPI), associated with chronic pancreatitis (CP) and cystic fibrosis (CF). AZX1101 is a recombinant-lactamase combination of bacterial origin under development for the prevention of hospital-acquired infections by resistant bacterial strains induced by parenteral administration of b-lactam antibiotics (known as nosocomial infections), as well as the prevention of antibiotic-associated diarrhea (AAD).

Full AZRX Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this AZRX vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AZRX vs SCHDAZRX vs JEPIAZRX vs OAZRX vs KOAZRX vs MAINAZRX vs MOAZRX vs PMAZRX vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.